Merck KGaA hands over CART therapy business to Intrexon in deal worth $175 million httpbit.ly2CrEDSJÂ oncology cancer pharma

Merck KGaA hands over CAR-T therapy business to @Intrexon in deal worth $175 million: http://bit.ly/2CrEDSJ  #oncology #cancer #pharma

02:00 EST 21 Dec 2018 | Pharmafile

Merck KGaA hands over CAR-T therapy business to @Intrexon in deal worth $175 million: http://bit.ly/2CrEDSJ  #oncology #cancer #pharma

More From BioPortfolio on "Merck KGaA hands over CAR-T therapy business to @Intrexon in deal worth $175 million: http://bit.ly/2CrEDSJ  #oncology #cancer #pharma"